Mondelez International Inc Chairman and CEO Dirk Van de Put filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 129,285 shares of Mondelez common stock through a Rule 10b5-1 plan adopted on May 15, 2026.
Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on November 4, 2026 disclosing a series of transactions in the company's common stock executed on November 2, 2026.
Christopher R. Fenimore, EVP Finance and CFO of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on November 4, 2026, disclosing multiple transactions in Regeneron common stock dated November 2, 2026.
Director George L. Sing of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) filed a Form 4 on November 4, 2026, disclosing option exercises and open-market share sales totaling 21,129 shares on November 2, 2026.
Director Christine A. Poon filed a Form 4 with the SEC on November 4, 2026, disclosing the exercise of a non-qualified stock option and the sale of 7,830 shares of Regeneron Pharmaceuticals, Inc. common stock on November 2, 2026.
Jason Pitofsky, an officer of Regeneron Pharmaceuticals Inc, filed a Form 144 notice of proposed sale on November 4, 2026, covering 3,883 shares of common stock to be sold through UBS Financial Services Inc on NASDAQ:REGN.
Jason Pitofsky, an officer of Regeneron Pharmaceuticals, Inc., filed a Form 144 notice of proposed sale on November 4, 2026, covering 180 shares of Regeneron common stock acquired through inheritance.
James Saccaro, a former officer of GE HealthCare Technologies Inc., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 78,348 shares of common stock on NASDAQ:GEHC.
Director Patrick L. Alexander of Landmark Bancorp Inc filed a Form 144 notice of proposed sale on November 4, 2026, covering 2,020 common shares with an aggregate market value of $65,650.00, to be sold on NASDAQ through RBC Capital Markets LLC.
Intercontinental Exchange, Inc. officer James Namkung filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 3,777 shares of common stock on the NYSE with an aggregate market value of $645,602.61.